Page last updated: 2024-10-22

amobarbital and Cerebral Infarction

amobarbital has been researched along with Cerebral Infarction in 1 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maeshima, S1
Nakagawa, M1
Terada, T1
Nakai, K1
Itakura, T1
Komai, N1
Roger, P1

Other Studies

1 other study available for amobarbital and Cerebral Infarction

ArticleYear
Transcortical mixed aphasia from ischaemic infarcts in a non-right handed patient.
    Journal of neurology, 1999, Volume: 246, Issue:6

    Topics: Adult; Amobarbital; Aphasia; Brain; Cerebral Infarction; Dominance, Cerebral; Echolalia; Humans; Hyp

1999